Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prospective Study to Discover New Biomarkers for Early Detection of Sepsis and Prediction of Sepsis-related Mortality in Patients With Severe Community Acquired Pneumonia (sCAP)

NCT04280354 is registered in ClinicalTrials.gov with University Hospital, Basel, Switzerland as lead sponsor.

NCT NCT04280354
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04280354 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prospective Study to Discover New Biomarkers for Early Detection of Sepsis and Prediction of Sepsis-related Mortality in Patients With Severe Community Acquired Pneumonia (sCAP)
Lead sponsor
University Hospital, Basel, Switzerland
Phase
Observational
Overall status
Terminated
Start date
February 16, 2022
Completion date
July 31, 2022
Enrollment
3 (actual)
Sites
15

Conditions

As the registry lists them; a condition with its own page is linked.

infection, bacterial, sepsis, severe community-acquired pneumonia (scap)